| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 702045 | 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- | 0.0235234559682125 | 0.47300754 |
| NSC 710342 | 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyophenyl)-5,7-dihydroxy-3,6,8-tris(3-methyl-2-butenyl)- (9CI) | 0.0235234559682125 | 0.2460382 |
| NSC 716679 | Null | 0.0235234559682125 | 0.42153011 |
| NSC 723906 | 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline | 0.0235234559682125 | 0.59979463 |
| NSC 724784 | (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 | 0.0235234559682125 | 0.46976594 |
| NSC 671806 | Null | 0.0235234559682126 | 0.038873113 |
| NSC 174121 | Methotrexate Derivative | 0.0235234559682128 | 0.3876975 |
| NSC 117915 | 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] | 0.0238174255956147 | 0.1055305 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0238174255956147 | 0.25216546 |
| NSC 123463 | Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) | 0.0238174255956147 | 0.24804139 |